Projected Income Statement: Safran

Forecast Balance Sheet: Safran

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,544 -14 -374 -1,738 -1,738 -3,738 -5,564 -8,020
Change - -100.91% -2,571.43% -364.71% 0% -115.07% -48.85% -44.14%
Announcement Date 24/02/22 17/02/23 15/02/24 14/02/25 12/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Safran

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 387 498 823 1,044 1,238 1,767 1,810 1,827
Change - 28.68% 65.26% 26.85% 18.58% 42.74% 2.41% 0.97%
Free Cash Flow (FCF) 1 1,680 2,666 2,945 3,189 3,921 4,556 5,012 5,590
Change - 58.69% 10.47% 8.29% 22.95% 16.19% 10.02% 11.52%
Announcement Date 24/02/22 17/02/23 15/02/24 14/02/25 12/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Safran

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 18.21% 19.26% 19.82% 19.82% 22.39% 21.55% 21.81% 21.99%
EBIT Margin (%) 11.83% 12.65% 13.65% 15.08% 16.59% 17.42% 17.84% 18.23%
EBT Margin (%) 1.76% -16.39% 20.5% -3.14% 32.78% 17.21% 17.88% 18.71%
Net margin (%) 0.28% -12.92% 14.85% -2.44% 22.91% 11.06% 12.55% 13%
FCF margin (%) 11.01% 14.01% 12.69% 11.67% 12.52% 12.75% 12.8% 13.13%
FCF / Net Income (%) 3,906.98% -108.42% 85.51% -478.11% 54.63% 115.23% 101.99% 101.08%

Profitability

        
ROA 1.87% 2.66% 4.17% 5.82% 5.43% 6.53% 7.47% 7.88%
ROE 6.03% 10.13% 18.45% 28.21% 25.38% 26.14% 28.45% 27.41%

Financial Health

        
Leverage (Debt/EBITDA) 0.56x - - - - - - -
Debt / Free cash flow 0.92x - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 2.54% 2.62% 3.55% 3.82% 3.95% 4.94% 4.62% 4.29%
CAPEX / EBITDA (%) 13.93% 13.58% 17.9% 19.29% 17.65% 22.94% 21.19% 19.53%
CAPEX / FCF (%) 23.04% 18.68% 27.95% 32.74% 31.57% 38.79% 36.1% 32.69%

Items per share

        
Cash flow per share 1 5.535 8.054 9.899 11.25 13.69 14.47 16.61 18.58
Change - 45.5% 22.9% 13.65% 21.7% 5.71% 14.8% 11.81%
Dividend per Share 1 0.5 1.35 1.35 2.9 3.35 3.984 4.889 5.487
Change - 170% 0% 114.81% 15.52% 18.92% 22.72% 12.24%
Book Value Per Share 1 30.09 24.52 26.84 24.19 35.51 37.74 43.25 50.14
Change - -18.5% 9.44% -9.88% 46.81% 6.27% 14.62% 15.92%
EPS 1 0.1 -5.76 8.07 -1.6 17.17 9.504 12.02 13.35
Change - -5,860% 240.1% -119.83% 1,173.12% -44.65% 26.48% 11.02%
Nbr of stocks (in thousands) 4,26,262 4,26,828 4,17,625 4,16,751 4,17,373 4,15,050 4,15,050 4,15,050
Announcement Date 24/02/22 17/02/23 15/02/24 14/02/25 12/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E ratio 31x 24.5x
PBR 7.81x 6.82x
EV / Sales 3.32x 2.98x
Yield 1.35% 1.66%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
294.80EUR
Average target price
343.79EUR
Spread / Average Target
+16.62%

Quarterly revenue - Rate of surprise